{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:18:00Z","timestamp":1791249480904,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T00:00:00Z","timestamp":1295568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T00:00:00Z","timestamp":1295568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1038\/leu.2010.325","type":"journal-article","created":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T09:41:08Z","timestamp":1295602868000},"page":"629-637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein"],"prefix":"10.1038","volume":"25","author":[{"given":"A S M","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B N","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Eniafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Keyvanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kurlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,21]]},"reference":[{"key":"BFleu2010325_CR1","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nrc1991","volume":"6","author":"A Sparmann","year":"2006","unstructured":"Sparmann A, van LM . Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006; 6: 846\u2013856.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2010325_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ceb.2008.01.004","volume":"20","author":"AM Pietersen","year":"2008","unstructured":"Pietersen AM, van LM . Stem cell regulation by polycomb repressors: postponing commitment. Curr Opin Cell Biol 2008; 20: 201\u2013207.","journal-title":"Curr Opin Cell Biol"},{"key":"BFleu2010325_CR3","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1634\/stemcells.2006-0608","volume":"25","author":"VK Rajasekhar","year":"2007","unstructured":"Rajasekhar VK, Begemann M . Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective. Stem Cells 2007; 25: 2498\u20132510.","journal-title":"Stem Cells"},{"key":"BFleu2010325_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature01587","volume":"423","author":"IK Park","year":"2003","unstructured":"Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL et al. BMI-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302\u2013305.","journal-title":"Nature"},{"key":"BFleu2010325_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2004.11.004","volume":"21","author":"A Iwama","year":"2004","unstructured":"Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product BMI-1. Immunity 2004; 21: 843\u2013851.","journal-title":"Immunity"},{"key":"BFleu2010325_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J Lessard","year":"2003","unstructured":"Lessard J, Sauvageau G . BMI-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423: 255\u2013260.","journal-title":"Nature"},{"key":"BFleu2010325_CR7","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1182\/blood-2007-08-106666","volume":"111","author":"A Rizo","year":"2008","unstructured":"Rizo A, Dontje B, Vellenga E, de Haan G, Schuringa JJ . Long-term maintenance of human hematopoietic stem\/progenitor cells by expression of BMI1. Blood 2008; 111: 2621\u20132630.","journal-title":"Blood"},{"key":"BFleu2010325_CR8","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1182\/blood-2009-03-209734","volume":"114","author":"A Rizo","year":"2009","unstructured":"Rizo A, Olthof S, Han L, Vellenga E, de Haan HG, Schuringa JJ . Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis. Blood 2009; 114: 1498\u20131505.","journal-title":"Blood"},{"key":"BFleu2010325_CR9","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","volume":"116","author":"A Rizo","year":"2010","unstructured":"Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R et al. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. Blood 2010; 116: 4621\u20134630.","journal-title":"Blood"},{"key":"BFleu2010325_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1182\/blood-2006-12-065599","volume":"110","author":"M Mohty","year":"2007","unstructured":"Mohty M, Yong AS, Szydlo RM, Apperley JF, Melo JV . The polycomb group BMI-1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. Blood 2007; 110: 380\u2013383.","journal-title":"Blood"},{"key":"BFleu2010325_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00277-008-0603-8","volume":"88","author":"J Bhattacharyya","year":"2009","unstructured":"Bhattacharyya J, Mihara K, Yasunaga S, Tanaka H, Hoshi M, Takihara Y et al. BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia. Ann Hematol 2009; 88: 333\u2013340.","journal-title":"Ann Hematol"},{"key":"BFleu2010325_CR12","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1172\/JCI23412","volume":"115","author":"GV Glinsky","year":"2005","unstructured":"Glinsky GV, Berezovska O, Glinskii AB . Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005; 115: 1503\u20131521.","journal-title":"J Clin Invest"},{"key":"BFleu2010325_CR13","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/sj.leu.2404623","volume":"21","author":"M Chowdhury","year":"2007","unstructured":"Chowdhury M, Mihara K, Yasunaga S, Ohtaki M, Takihara Y, Kimura A . Expression of polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia 2007; 21: 1116\u20131122.","journal-title":"Leukemia"},{"key":"BFleu2010325_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1182\/blood-2005-06-2393","volume":"107","author":"K Mihara","year":"2006","unstructured":"Mihara K, Chowdhury M, Nakaju N, Hidani S, Ihara A, Hyodo H et al. BMI-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. Blood 2006; 107: 305\u2013308.","journal-title":"Blood"},{"key":"BFleu2010325_CR15","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1182\/blood-2008-04-148130","volume":"112","author":"M Mohty","year":"2008","unstructured":"Mohty M, Szydlo RM, Yong AS, Apperley JF, Goldman JM, Melo JV . Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia. Blood 2008; 112: 2163\u20132166.","journal-title":"Blood"},{"key":"BFleu2010325_CR16","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1182\/blood-2005-09-3585","volume":"107","author":"LM Kamminga","year":"2006","unstructured":"Kamminga LM, Bystrykh LV, de Boer A, Houwer S, Douma J, Weersing E et al. The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood 2006; 107: 2170\u20132179.","journal-title":"Blood"},{"key":"BFleu2010325_CR17","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/sj.bjc.6603369","volume":"95","author":"JC Steele","year":"2006","unstructured":"Steele JC, Torr EE, Noakes KL, Kalk E, Moss PA, Reynolds GM et al. The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens. Br J Cancer 2006; 95: 1202\u20131211.","journal-title":"Br J Cancer"},{"key":"BFleu2010325_CR18","doi-asserted-by":"crossref","unstructured":"Fujii N, Turtle CJ, Campregher PV, Warren EH . Generation of CD8+ cytotoxic T cell clones recognizing BMI1-derived peptides. Blood 2008; 112, Abstract 2909.","DOI":"10.1182\/blood.V112.11.2909.2909"},{"key":"BFleu2010325_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(84)92179-2","volume":"1","author":"B Speck","year":"1984","unstructured":"Speck B, Bortin MM, Champlin R, Goldman JM, Herzig RH, McGlave PB et al. Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia. Lancet 1984; 1: 665\u2013668.","journal-title":"Lancet"},{"key":"BFleu2010325_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1182\/blood-2007-02-071738","volume":"110","author":"AS Yong","year":"2007","unstructured":"Yong AS, Rezvani K, Savani BN, Eniafe R, Mielke S, Goldman JM et al. High PR3 or ELA2 expression by CD34+ cells in advanced phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide driven graft-versus-leukemia effects. Blood 2007; 110: 770\u2013775.","journal-title":"Blood"},{"key":"BFleu2010325_CR21","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1182\/blood-2005-05-1897","volume":"107","author":"BN Savani","year":"2006","unstructured":"Savani BN, Rezvani K, Mielke S, Montero A, Kurlander R, Carter CS et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 2006; 107: 1688\u20131695.","journal-title":"Blood"},{"key":"BFleu2010325_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/sj.bmt.1704231","volume":"32","author":"E Sloand","year":"2003","unstructured":"Sloand E, Childs RW, Solomon S, Greene A, Young NS, Barrett AJ . The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia. Bone Marrow Transplant 2003; 32: 897\u2013901.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2010325_CR23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1182\/blood.V96.1.86","volume":"96","author":"C Craddock","year":"2000","unstructured":"Craddock C, Szydlo RM, Klein JP, Dazzi F, Olavarria E, van Rhee F et al. Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission. Blood 2000; 96: 86\u201390.","journal-title":"Blood"},{"key":"BFleu2010325_CR24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1182\/blood.V86.2.813.bloodjournal862813","volume":"86","author":"A Gratwohl","year":"1995","unstructured":"Gratwohl A, Hermans J, Apperley J, Arcese W, Bacigalupo A, Bandini G et al. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Blood 1995; 86: 813\u2013818.","journal-title":"Blood"},{"key":"BFleu2010325_CR25","first-page":"250","volume":"28","author":"KM Sullivan","year":"1991","unstructured":"Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250\u2013259.","journal-title":"Semin Hematol"},{"key":"BFleu2010325_CR26","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1182\/blood-2007-08-108241","volume":"111","author":"K Rezvani","year":"2008","unstructured":"Rezvani K, Yong AS, Mielke S, Savani BN, Musse L, Superata J et al. Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies. Blood 2008; 111: 236\u2013242.","journal-title":"Blood"},{"key":"BFleu2010325_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1182\/blood-2005-05-2155","volume":"107","author":"AS Yong","year":"2006","unstructured":"Yong AS, Szydlo RM, Goldman JM, Apperley JF, Melo JV . Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML. Blood 2006; 107: 205\u2013212.","journal-title":"Blood"},{"key":"BFleu2010325_CR28","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1182\/blood-2008-03-144071","volume":"113","author":"K Rezvani","year":"2009","unstructured":"Rezvani K, Yong AS, Tawab A, Jafarpour B, Eniafe R, Mielke S et al. Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia. Blood 2009; 113: 2245\u20132255.","journal-title":"Blood"},{"key":"BFleu2010325_CR29","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/leu.2009.70","volume":"23","author":"G Weber","year":"2009","unstructured":"Weber G, Karbach J, Kuci S, Kreyenberg H, Willasch A, Koscielniak E et al. WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation. Leukemia 2009; 23: 1634\u20131642.","journal-title":"Leukemia"},{"key":"BFleu2010325_CR30","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.bbmt.2006.08.034","volume":"12","author":"A Montero","year":"2006","unstructured":"Montero A, Savani BN, Shenoy A, Read EJ, Carter CS, Leitman SF et al. T cell depleted peripheral blood stem cell allotransplantation with T cell add back for patients with hematological malignancies: effect of chronic GVHD on outcome. Biol Blood Marrow Transplant 2006; 12: 1318\u20131325.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2010325_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1172\/JCI200316398","volume":"111","author":"JJ Molldrem","year":"2003","unstructured":"Molldrem JJ, Lee PP, Kant S, Wieder E, Jiang W, Lu S et al. Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. J Clin Invest 2003; 111: 639\u2013647.","journal-title":"J Clin Invest"},{"key":"BFleu2010325_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.beha.2009.05.002","volume":"22","author":"A Gratwohl","year":"2009","unstructured":"Gratwohl A, Heim D . Current role of stem cell transplantation in chronic myeloid leukaemia. Best Pract Res Clin Haematol 2009; 22: 431\u2013443.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFleu2010325_CR33","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1182\/blood-2008-06-162388","volume":"112","author":"D Marin","year":"2008","unstructured":"Marin D, Milojkovic D, Olavarria E, Khorashad JS, de Lavallade H, Reid AG et al. European LeukemiaNet criteria for failure or sub-optimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor. Blood 2008; 112: 4437\u20134444.","journal-title":"Blood"},{"key":"BFleu2010325_CR34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/sj.leu.2404609","volume":"21","author":"X Jiang","year":"2007","unstructured":"Jiang X, Zhao Y, Smith C, Gasparetto M, Turhan A, Eaves A et al. Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies. Leukemia 2007; 21: 926\u2013935.","journal-title":"Leukemia"},{"key":"BFleu2010325_CR35","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/sj.leu.2405086","volume":"22","author":"H Konig","year":"2008","unstructured":"Konig H, Holtz M, Modi H, Manley P, Holyoake TL, Forman SJ et al. Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia 2008; 22: 748\u2013755.","journal-title":"Leukemia"},{"key":"BFleu2010325_CR36","doi-asserted-by":"publisher","first-page":"8210","DOI":"10.4049\/jimmunol.174.12.8210","volume":"174","author":"M Gannage","year":"2005","unstructured":"Gannage M, Abel M, Michallet AS, Delluc S, Lambert M, Giraudier S et al. Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy. J Immunol 2005; 174: 8210\u20138218.","journal-title":"J Immunol"},{"issue":"24 Part 1","key":"BFleu2010325_CR37","doi-asserted-by":"publisher","first-page":"8799","DOI":"10.1158\/1078-0432.CCR-05-1314","volume":"11","author":"K Rezvani","year":"2005","unstructured":"Rezvani K, Brenchley JM, Price DA, Kilical Y, Gostick E, Sewell AK et al. T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization. Clin Cancer Res 2005; 11 (24 Part 1): 8799\u20138807.","journal-title":"Clin Cancer Res"},{"key":"BFleu2010325_CR38","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1182\/blood-2009-12-260760","volume":"116","author":"IJ Majewski","year":"2010","unstructured":"Majewski IJ, Ritchie ME, Phipson B, Corbin J, Pakusch M, Ebert A et al. Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells. Blood 2010; 116: 731\u2013739.","journal-title":"Blood"},{"key":"BFleu2010325_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.leukres.2009.09.026","volume":"34","author":"H de Lavallade","year":"2010","unstructured":"de Lavallade H, Finetti P, Carbuccia N, Khorashad JS, Charbonnier A, Foroni L et al. A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia. Leuk Res 2010; 34: 254\u2013257.","journal-title":"Leuk Res"},{"key":"BFleu2010325_CR40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V92.1.198.413k13_198_206","volume":"92","author":"JE Schmitz","year":"1998","unstructured":"Schmitz JE, Forman MA, Lifton MA, Concepcion O, Reimann Jr KA, Crumpacker CS et al. Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus\u2212 and human immunodeficiency virus+ individuals. Blood 1998; 92: 198\u2013206.","journal-title":"Blood"},{"key":"BFleu2010325_CR41","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ni1512","volume":"8","author":"JH Park","year":"2007","unstructured":"Park JH, Adoro S, Lucas PJ, Sarafova SD, Alag AS, Doan LL et al. \u2018Coreceptor tuning\u2019: cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR. Nat Immunol 2007; 8: 1049\u20131059.","journal-title":"Nat Immunol"},{"key":"BFleu2010325_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/bmt.2008.426","volume":"43","author":"M Kapp","year":"2009","unstructured":"Kapp M, Stevanovic S, Fick K, Tan SM, Loeffler J, Opitz A et al. CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT. Bone Marrow Transplant 2009; 43: 399\u2013410.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2010325_CR43","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1182\/blood-2009-10-248997","volume":"115","author":"EH Warren","year":"2010","unstructured":"Warren EH, Fujii N, Akatsuka Y, Chaney CN, Mito JK, Loeb KR et al. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens. Blood 2010; 115: 3869\u20133878.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2010325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010325","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:53:11Z","timestamp":1648734791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,21]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["BFleu2010325"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.325","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,21]]},"assertion":[{"value":"10 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}